Amgen, Inc. recalls Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60
Presence of Foreign Substance.
Read the official notice →- Date
- 2026-07-01
- Country
- United States
- Brand
- Amgen
- Product
- Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60
- Classification
- Class II
- Units
- Nationwide within the United States
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Amgen recalls
- 2026-07-01
US- 2025-03-26
- US
Amgen, Inc. recalls Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile…
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
FDA · DrugAmgen, Inc.Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia,…Official notice → - 2022-05-18
- US
Amgen, Inc. recalls MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by…
Defective container: loose crimp defect, potential loss of container integrity.
Other drugs & medical recalls in the United States
- 2026-07-01
- US
- US
Central Admixture Pharmacy Services, Inc. recalls Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound…
Incorrect product formulation: bag did not contain copper and famotidine per label.
- US
Direct Rx recalls DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps; CYMBALTA, Packaged and Distributed by Direct Rx.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
- US
- US
- US